GLICLAGLAZE M 80

Description

GLICLAGLAZE M 80 gliclazide (80mg),Metformin (500 mg) Type 2 diabetes mellitus is one of the most common lifestyle-related health conditions affecting millions of people across India. Poor dietary habits, lack of physical activity, obesity, and genetic predisposition significantly contribute to rising blood sugar levels. Effective glycaemic control is essential to prevent long-term complications such as heart disease, kidney problems, nerve damage, and vision impairment. GLICLAGLAZE M 80 is a clinically proven combination of Gliclazide 80 mg and Metformin Hydrochloride 500 mg Tablets, designed to provide comprehensive blood glucose control in adults with type 2 diabetes. This dual-action formulation helps regulate insulin secretion while improving insulin sensitivity, offering balanced and sustained glucose management when diet and exercise alone are insufficient. Uses of Gliclazide 80 mg and Metformin Hydrochloride 500 mg Tablets GLICLAGLAZE M 80 is primarily prescribed for the management of type 2 diabetes mellitus in adults. It is recommended when monotherapy with either metformin or a sulfonylurea does not achieve adequate glycaemic control. Key uses include: Control of high blood sugar levels in type 2 diabetes Improvement of insulin response in the body Reduction of post-meal and fasting blood glucose levels Prevention of diabetes-related complications affecting the heart, kidneys, nerves, and eyes Adjunct therapy along with dietary modifications and regular exercise This combination is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis. Benefits of GLICLAGLAZE M 80 GLICLAGLAZE M 80 offers multiple therapeutic benefits due to the complementary actions of its two active ingredients. Dual Mechanism for Effective Sugar Control Gliclazide stimulates insulin release from the pancreas, helping lower blood sugar levels after meals. Metformin works by reducing glucose production in the liver and improving insulin sensitivity in peripheral tissues. Together, they provide effective and sustained glycaemic control. Helps Maintain Stable Blood Glucose Levels The combination targets both fasting and postprandial blood sugar levels, reducing daily fluctuations and supporting better long-term diabetes management. Lowers Risk of Diabetes Complications Consistent blood sugar control helps reduce the risk of complications such as cardiovascular disease, neuropathy, nephropathy, and retinopathy. Weight-Neutral or Minimal Weight Gain Metformin is known for its weight-neutral effect, which helps counterbalance the potential weight gain associated with sulfonylureas, making this combination suitable for long-term use under medical supervision. Improves Overall Metabolic Health By enhancing insulin efficiency and reducing insulin resistance, GLICLAGLAZE M 80 supports better metabolic balance and energy utilisation. Dosage The dosage of GLICLAGLAZE M 80 should be determined by a healthcare professional based on individual blood glucose levels and treatment response. Usually taken once or twice daily, preferably with meals Tablets should be swallowed whole with water Do not crush or chew the tablet unless advised by a doctor Regular monitoring of blood sugar levels is essential to adjust the dosage and avoid complications such as hypoglycaemia. Side Effects Most patients tolerate GLICLAGLAZE M 80 well when taken as prescribed. However, some may experience mild to moderate side effects. Common side effects include: Nausea or vomiting Stomach discomfort or diarrhoea Headache Dizziness Mild hypoglycaemia (low blood sugar), especially if meals are skipped Rare but serious side effects may include severe hypoglycaemia or lactic acidosis (associated with metformin). Immediate medical attention is required if symptoms such as extreme weakness, rapid breathing, or unusual drowsiness occur. Precautions and Warning Certain precautions should be followed before using GLICLAGLAZE M 80: Not recommended for patients with severe kidney or liver disease Alcohol intake should be avoided, as it increases the risk of hypoglycaemia and lactic acidosis Caution is advised in elderly patients Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding Not suitable for type 1 diabetes or diabetic ketoacidosis Regular blood sugar and kidney function monitoring is advised Always follow medical guidance and do not adjust the dose on your own. Conclusion GLICLAGLAZE M 80 – Gliclazide 80 mg and Metformin Hydrochloride 500 mg Tablets is an effective and well-balanced oral antidiabetic medication designed to help adults manage type 2 diabetes efficiently. By combining two complementary mechanisms, it provides improved blood sugar control, supports metabolic health, and reduces the risk of long-term complications.